Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Sofosbuvir und Velpatasvir, ATC J05AP55 für die Zeit 01.05.2024 - 30.04.2026
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- Abacus Medicine A/S, axicorp Pharma B.V., CC Pharma GmbH, EurimPharm Arzneimittel GmbH, Gilead Sciences GmbH, kohlpharma GmbH, Orifarm GmbH, Paranova Pack A/S
- Contract value
- no value published
- Bids received
- 6
- Published
- 5 May 2026
- Awarded
- 1 May 2024
- Contract start
- 1 May 2024
- Contract end
- 14 May 2025estimated
- Region
- Hamburg